Hao-Yuan Chuang

CIK: 0001992008

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)25 (89.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (3.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (7.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BLTE

BELITE BIO, INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (28 total)

BLTE
BELITE BIO, INC
Oct 29, 2026
Other(J)
Direct
5K shares-
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
4.6K shares at avg. $197.23$908K
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
2.6K shares at avg. $198.05$507K
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
4.5K shares at avg. $196.47$879K
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
2.2K shares at avg. $194.28$427K
BLTE
BELITE BIO, INC
Sep 8, 2026
Sale(S)
Direct
4.1K shares at avg. $195.60$806K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
4.6K shares at avg. $193.12$889K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
1.6K shares at avg. $180.16$294K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
2K shares at avg. $181.05$362K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
2K shares at avg. $182.49$365K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
3.8K shares at avg. $183.27$689K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
3.6K shares at avg. $184.57$659K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
3.9K shares at avg. $185.28$717K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
4.6K shares at avg. $186.34$857K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
3.9K shares at avg. $187.16$730K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
1.9K shares at avg. $188.59$358K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
6.2K shares at avg. $189.22$1.2M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
1.8K shares at avg. $190.63$343K
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
6.2K shares at avg. $191.09$1.2M
BLTE
BELITE BIO, INC
Sep 4, 2026
Sale(S)
Direct
3.4K shares at avg. $192.40$654K
BLTE
BELITE BIO, INC
Aug 12, 2026
Sale(S)
Direct
144 shares at avg. $180.00$26K
BLTE
BELITE BIO, INC
Aug 12, 2026
Sale(S)
Direct
223 shares at avg. $180.57$40K
BLTE
BELITE BIO, INC
Apr 21, 2026
Other(J)
Direct
10K shares-
BLTE
BELITE BIO, INC
Apr 9, 2026
Sale(S)
Direct
2K shares at avg. $180.35$361K
BLTE
BELITE BIO, INC
Apr 9, 2026
Sale(S)
Direct
2K shares at avg. $181.40$363K

		Type	Shares	Price		Ownership
Oct 29, 2026	BLTE BELITE BIO, INC	Other(J)	5,000	-	$0	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	4,605	$197.23	$908,244	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	2,562	$198.05	$507,392	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	4,475	$196.47	$879,200	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	2,200	$194.28	$427,414	Direct
Sep 8, 2026	BLTE BELITE BIO, INC	Sale(S)	4,120	$195.60	$805,889	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	4,602	$193.12	$888,727	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	1,633	$180.16	$294,201	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	2,000	$181.05	$362,107	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	2,000	$182.49	$364,985	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	3,759	$183.27	$688,899	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	3,569	$184.57	$658,744	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	3,872	$185.28	$717,408	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	4,600	$186.34	$857,187	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	3,900	$187.16	$729,942	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	1,900	$188.59	$358,318	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	6,200	$189.22	$1,173,191	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	1,800	$190.63	$343,140	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	6,200	$191.09	$1,184,754	Direct
Sep 4, 2026	BLTE BELITE BIO, INC	Sale(S)	3,398	$192.40	$653,788	Direct
Aug 12, 2026	BLTE BELITE BIO, INC	Sale(S)	144	$180.00	$25,920	Direct
Aug 12, 2026	BLTE BELITE BIO, INC	Sale(S)	223	$180.57	$40,267	Direct
Apr 21, 2026	BLTE BELITE BIO, INC	Other(J)	10,000	-	$0	Direct
Apr 9, 2026	BLTE BELITE BIO, INC	Sale(S)	2,000	$180.35	$360,695	Direct
Apr 9, 2026	BLTE BELITE BIO, INC	Sale(S)	2,000	$181.40	$362,790	Direct

1-25 of 28 transactions

About Chuang Hao-Yuan

Chuang Hao-Yuan (SEC CIK 0001992008) files insider reports with the SEC as Chief Financial Officer of BELITE BIO, INC (BLTE).

Signal8 holds 7 ownership filings by Chuang Hao-Yuan (1 Form 3, 6 Form 4), filed between Mar 18, 2026 and Oct 30, 2026. Those filings report 28 transactions, from Mar 31, 2026 to Oct 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chuang Hao-Yuan's filings is in SAN DIEGO, CA.

Recent filings by Chuang Hao-Yuan

Oct 29, 2026: Other transaction of BLTE shares (Form 4, code J).
Sep 8, 2026: Open-market sales of BLTE shares (5 lines, Form 4, code S).
Sep 4, 2026: Open-market sales of BLTE shares (14 lines, Form 4, code S).
Aug 12, 2026: Open-market sales of BLTE shares (2 lines, Form 4, code S).
Apr 21, 2026: Other transaction of BLTE shares (Form 4, code J).

Other insiders filing for BELITE BIO, INC (BLTE)

Lin Yu-Hsin, Chief Executive Officer
Chen Wan-Shan, Director
Scholl Hendrik Peter, Chief Medical Officer
MATA NATHAN L., Chief Scientific Officer
Chen Xiao-Hui, Director
Longo John Michael, Director

How to read Form 4 transaction codes